Committee
[용어속성] Term
A randomised, double-blind, placebo-controlled, pilot trial of intravenous plasma purified alpha-1 antitrypsin for SARS-CoV-2-induced Acute Respiratory Distress Syndrome: a structured summary of a study protocol for a randomised, controlled trial
SARS-CoV-2 유발 급성 호흡곤란 증후군에 대한 정맥내 혈장 정제 알파-1 항트립신의 무작위 이중 맹검 위약 대조 파일럿 시험: 무작위 대조 시험을 위한 연구 프로토콜의 구조화된 요약
Letter
[키워드] 24 hours
active malignancy
acute kidney
Acute kidney injury
acute respiratory distress syndrome
addition
Administered
administration
adverse event
adverse events
AEs
age
Alpha
alpha-1 antitrypsin
Amendment
Anti-viral
Antibiotics
anticipated
antitrypsin
antivirals
approval
approved
ARDS
ARMS
authority
bacterial pneumonia
baseline
Berlin criteria
blinded to treatment
Blinding
BMI
body weight
Cancer
changes in
Child-Pugh score
chloride
Chronic kidney disease
chronic liver disease
circulating
class
clinical
Clinical outcome
clinical trial
Combination
commenced
Committee
comparator
Complete
conducted
Consent
Controlled trial
correction
COVID-19
Culture
cytokine level
cytokine levels
Data collection
defined
determine
Diagnosis
diagnosis of ARDS
dialysis
dissemination
DNAR
double-blind
Echocardiogram
Effect
Effectiveness
elapsed
element
ELISA
enrolled
EudraCT
excluded
exclusion
exclusion criteria
facilitate
Follow-up
followed by
for inclusion
group
Health Products regulatory Authority
hospital
Hospital admission
hypertension
ICU
IgA deficiency
IL-10
IL-1β
IL-6
IL-8
incidence
inclusion criteria
individual
information
intensive care unit
intensive care units
interim analysis
interleukin
interleukin-10
interleukin-1β
interleukin-6
interleukin-8
interpreter
Intervention
intravenous
intravenous infusion
intravenously
invasive
investigational medicinal product
investigator
Ireland
Kidney disease
Laboratory
laboratory-confirmed
life
Local
maintain
major trauma
malignancy
mandatory
marker
mechanical ventilation
Microscopy
moderate
moderate to severe
Mortality
Non-invasive
non-invasive mechanical ventilation
non-invasive ventilation
number
objective
occur
Organ failure
outcome
outcome measure
PaO
participant
Patient
patient recruitment
patients with moderate
PCR-confirmed
Phase 2
physician
Placebo
placebo-controlled
plasma
plasma analysis
plasma concentration
plasma concentrations
pregnant
preparation
product
protocol
provided
Pulmonary embolism
pulmonary hypertension
purified
Radiographic
randomisation
randomisation list
randomised
randomised controlled trial
rationale
readmission
REC
receiving
receptor
recruited
recruitment
reduce
Regulatory
removal
renal
renal replacement therapy
replacement therapy
reported
required
Research
Research Ethics
Research Ethics Committee
research nurse
research nurses
respiratory
respiratory distress
Respiratory distress syndrome
resulting
Resuscitation
SAE
SAEs
Sample size
SARS-CoV-2
secondary
secondary bacterial pneumonia
Secondary objective
Secondary objectives
Secondary outcomes
secretion
Sequential Organ Failure Assessment
Serious Adverse Event
Serious Adverse Events
severe ARDS
Shock
single dose
skin cancer
Sodium chloride
SOFA
Standard
statistician
stratified
study participation
Study protocol
subject
submitted
supplementary material
Support
sustained
TNF
TNF-α
Tolerability
trauma
Treatment
treatment allocation
Trial
trial protocol
Trial registration
vasopressors
ventilator
verbal
Version
Volume
website
WHO
Withdrawal
writing
[DOI] 10.1186/s13063-021-05254-0 PMC 바로가기 [Article Type] Letter
[DOI] 10.1186/s13063-021-05254-0 PMC 바로가기 [Article Type] Letter
Analysis of Thrombotic Adverse Reactions of COVID-19 AstraZeneca Vaccine Reported to EudraVigilance Database
Article
[키워드] Adverse
Adverse drug reaction
adverse event
adverse events
Adverse reaction
Adverse reactions
Analysis
assessment
AstraZeneca
benefit
Blood
Characteristics
Committee
Comorbidities
Conducting
COVID-19
database
death
effective
EMA
European country
European Medicines Agency
event
fatality
group
identify
pandemic
pharmacovigilance
reaction
Research
retrospective
Safe
specificity
submitted
the vaccine
thrombosis
thrombotic
vaccination
Vaccine
Vaccines
World Health Organization’
[DOI] 10.3390/vaccines9040393 PMC 바로가기 [Article Type] Article
[DOI] 10.3390/vaccines9040393 PMC 바로가기 [Article Type] Article
The Society for Integrative Oncology Practice Recommendations for online consultation and treatment during the COVID-19 pandemic
Special Article
[키워드] Care
Committee
Consensus
COVID-19 pandemic
Doctor-patient communication
effective
Effects
element
expressive
force
healthcare
include
Integrative oncology
International
literature review
objective
oncology
pandemic
Patient
physical
Practice
Practice guidelines
Practitioner
questionnaire
recommendation
Result
resulting
Safe
Society
specific treatment
supplementary material
supportive care
Symptom management
Telemedicine
Therapies
Treatment
[DOI] 10.1007/s00520-021-06205-w PMC 바로가기 [Article Type] Special Article
[DOI] 10.1007/s00520-021-06205-w PMC 바로가기 [Article Type] Special Article
The efficacy of N-Acetylcysteine in severe COVID-19 patients: A structured summary of a study protocol for a randomised controlled trial
중증 COVID-19 환자에서 N-아세틸시스테인의 효능: 무작위 대조 시험을 위한 연구 프로토콜의 구조화된 요약
Letter
[키워드] 1:1
Acetylcysteine
Activation
Acute respiratory infection
addition
Admission
All participant
All participants
antioxidant effect
antioxidant effects
appearance
approved
Arm
assigned
Bandar Abba
Bandar Abbas
baseline
Blinding
block randomization
Care
caused
cell damage
clinical
clinical condition
clinical trial
clinical trials
Committee
comparator
Comparator group
composite endpoint
control group
Controlled clinical trial
COVID-19
discharge
dissemination
dose
Effects
Efficacy
element
ethics committee
evaluate
excluded
expected
FIVE
Health
Health care
help
Hospitalization
hypersensitivity
Hypoxemia
infiltration
inflammatory factors
injection
intensive care
intensive care unit
Intervention
intervention group
Intravenous injection
investigator
Lactate
lactate dehydrogenase
LDH
lead
Local
lung
lung failure
lymphopenia
mechanical ventilation
Medical Science
Medical Sciences
medication
minute
N-acetylcysteine
number
objective
outcome
oxygen
oxygen partial pressure
parallel-group
partial pressure
participant
Patient
patients
Pharmaceutical Company
Phase 3
Placebo
positive PCR test
Pregnancy
primary endpoint
principal investigator
Progressive
protocol
random
randomised
randomised controlled trial
randomization
Randomized
Randomly
reactive oxygen species
receive
recruitment
Registered
registry
reported
respiration rate
respiratory infection
Saline
Sample size
SARI
SARS-CoV-2 virus
sequence
severe COVID-19
severe COVID-19 patient
severe COVID-19 patients
Side effect
Standard
Standard of care
Sterile
sterile water
Study protocol
supplementary material
technology
test results
the ethics committee
the patient
the SARS-CoV-2 virus
Treatment
Trial registration
university
water
water for injection
website
were measured
written consent
[DOI] 10.1186/s13063-021-05242-4 PMC 바로가기 [Article Type] Letter
[DOI] 10.1186/s13063-021-05242-4 PMC 바로가기 [Article Type] Letter
A Malaysian Medical Non-Governmental Organization’s (NGO) Experience in the Emergency Response for COVID-19, Using the Whole-of-Society Collaborative Concept
Report from the Field
[키워드] approval
Committee
complement
concept
coronavirus
coronavirus disease
COVID-19
database
Donor
effort
Emergency
ENhance
equipment
experience
force
Health
intersectoral collaboration
majority
Malaysia
medical doctors
medical societies
Non-governmental organization
overcome
pandemic
Personal protective equipment
raised
relief
response
retrieved
supply
Support
team
Volunteer
volunteers
[DOI] 10.1017/dmp.2021.106 PMC 바로가기 [Article Type] Report from the Field
[DOI] 10.1017/dmp.2021.106 PMC 바로가기 [Article Type] Report from the Field
Evidence and speculations: vaccines and therapeutic options for COVID-19 pandemic
증거 및 추측: COVID-19 전염병에 대한 백신 및 치료 옵션
Review
[키워드] 2019-nCoV
accelerate
acute respiratory syndrome
antiviral therapeutics
Characteristics
China
Committee
consequence
coronavirus
coronavirus disease
COVID-19
COVID-19 disease
COVID-19 pandemic
disease
drugs
Emergency
evaluate
Genome
global pandemic
Health
Health Organization
highlight
human health
ICTV
mechanisms
molecular virology
Novel coronavirus
protocol
Public
question
recent finding
recent findings
required
respiratory
SARS-CoV-2
severe acute respiratory syndrome Coronavirus
severe acute respiratory syndrome coronavirus-2
Side effect
Side effects
taxonomy
the disease
therapeutic
therapeutic option
therapeutic options
Transmission
Vaccine
Vaccine development
viruses
WHO
World Health Organization
[DOI] 10.1080/21645515.2020.1824497 PMC 바로가기 [Article Type] Review
[DOI] 10.1080/21645515.2020.1824497 PMC 바로가기 [Article Type] Review
Prophylaxis for COVID-19: a systematic review
COVID-19 예방: 체계적인 검토
Article
Published on
Journal: Clinical microbiology and infection : the official [Category] MERS, SARS, 비임상, 임상, 진단, 치료제,
Journal: Clinical microbiology and infection : the official [Category] MERS, SARS, 비임상, 임상, 진단, 치료제,
[키워드] acute respiratory syndrome
acute respiratory syndrome coronavirus
acute respiratory syndrome coronavirus 2
animals
antibodies
breath
candidate
Candidates
clinical
clinical trial registry
Committee
controlled trials
coronavirus
coronavirus disease
Coronavirus disease 2019
COVID-19
Cross-sectional studies
cross-sectional study
database
eligibility criteria
evaluated
Evidence
FIVE
HCQ
Human
Hydroxychloroquine
identify
inclusion criteria
journal
landscape
majority
medRxiv
Novel coronavirus
novel coronavirus disease
other compounds
outcome
populations
PrEP
Prophylactic
Prophylaxis
Randomized control trials
Randomized controlled trial
RCT
RCTs
registries
registry
reported
respiratory
SARS-CoV-2
systematic review
Treatment
Vaccine
Vaccines
Vitamin
vitamins
while
[DOI] 10.1016/j.cmi.2021.01.013 PMC 바로가기 [Article Type] Article
[DOI] 10.1016/j.cmi.2021.01.013 PMC 바로가기 [Article Type] Article
Therapeutic Approach against 2019-nCoV by Inhibition of ACE-2 Receptor
ACE-2 수용체 억제에 의한 2019-nCoV에 대한 치료적 접근
Review
[키워드] 1-piperoylpiperidine
2019-nCoV
ACE-2
ACE-2 receptor
binding domain
Bioavailability
catechin
Committee
complex
COVID-19
Curcuma
Curcumin
effective
effort
ENhance
glucuronidation
green tea
host cell
Immunity
IMPROVE
inhibit
inhibition
Intervention
liver
lockdown
pathogen
piperine
presenting
receptor
researcher
respiratory
S-protein
SARS-CoV-2
Severe acute respiratory syndrome
severe acute respiratory syndrome Coronavirus
severe acute respiratory syndrome coronavirus-2
social distancing
Spread
taxonomy
therapeutic agent
Transmission
Vaccine
viral disease
virus
WHO
widespread
[DOI] 10.1055/a-1275-0228 PMC 바로가기 [Article Type] Review
[DOI] 10.1055/a-1275-0228 PMC 바로가기 [Article Type] Review
Management of Acute Appendicitis during COVID-19 Pandemic in a Tertiary Care Centre: A Descriptive Cross-sectional Study
Original Article
[키워드] acute appendicitis
antibiotics
appendectomy
non-operative management
abdominal surgery
Acute appendicitis
Appendicitis
calculated
Care
children
clearance
Committee
complicate
Complication
conducted
confidence
Conservative
Conservative management
Course
COVID-19
cross-sectional
Data collection
diagnosed
excluded
Frequency
gold standard
health system
interval
involved
lack
Lung injury
management
multiple organ dysfunction
outbreak
pandemic
proportion
resources
review
Science
Statistical Package
Tertiary
the patient
threat
Trial
undergo
was collected
was done
[DOI] 10.31729/jnma.6307 PMC 바로가기 [Article Type] Original Article
[DOI] 10.31729/jnma.6307 PMC 바로가기 [Article Type] Original Article